VERIFIED AMERICAN MANUFACTURERS

Aphena Pharma Solutions operates a state-of-the-art pharmaceutical manufacturing facility in Cookeville, Tennessee, serving as one of the premier contract pharmaceutical manufacturers in the United States. The Cookeville solid dose division specializes in comprehensive pharmaceutical manufacturing and packaging services, positioned strategically to serve customers across the nation. The facility excels in solid dose pharmaceutical manufacturing, offering advanced capabilities in tablet and capsule production with rigorous quality control standards. Aphena Pharma maintains FDA registration and DEA licensing for controlled substances (CII-V), ensuring compliance with the highest pharmaceutical manufacturing regulations. The company holds multiple certifications including cGMP compliance, ISO 13485:2016 for medical devices, and ISO 9001:2015 for quality management systems. Manufacturing capabilities encompass the full spectrum of pharmaceutical products including tablets, capsules, and specialized formulations. The facility provides comprehensive packaging solutions featuring blister carding, bottling operations, and unit-of-use packaging systems. Advanced quality assurance protocols ensure product integrity throughout the manufacturing process. Aphena Pharma Solutions serves diverse markets including pharmaceutical companies, over-the-counter manufacturers, dietary supplement producers, and medical device companies. The Cookeville facility combines cutting-edge technology with experienced pharmaceutical professionals to deliver reliable contract manufacturing services. With a commitment to operational excellence and regulatory compliance, the company provides scalable manufacturing solutions from development through commercial production, supporting clients with flexible capacity and specialized pharmaceutical expertise.

August Bioservices LLC is a fully integrated contract development and manufacturing organization headquartered in Nashville, Tennessee, specializing in sterile injectable pharmaceutical products. The company provides comprehensive drug development, testing, and manufacturing services across the entire product lifecycle, supporting biotechnology and pharmaceutical companies in bringing life-altering therapies to market faster. August Bioservices offers extensive analytical services including method development and validation, raw material release testing, USP injectable testing, stability studies, and impurity analysis. Their development capabilities encompass process development and optimization through Design of Experiments and Quality by Design methodologies, along with technology transfer and scale-up services. The Nashville facility features advanced manufacturing capabilities with formulation scales ranging from 1L to 4000L, multiple filling lines for vials, syringes, and IV bags, plus automated visual inspection, packaging, and serialization systems. This state-of-the-art infrastructure enables efficient production of sterile injectable pharmaceuticals while maintaining the highest quality standards. What distinguishes August Bioservices in the competitive CDMO landscape is their collaborative approach and commitment to cutting-edge science combined with end-to-end service capabilities. The company focuses on delivering comprehensive solutions that streamline the path from development through commercial manufacturing, helping clients accelerate their pharmaceutical programs while ensuring regulatory compliance and product quality throughout the manufacturing process.

Crown Laboratories Inc stands as a leading fully integrated specialty pharmaceutical company headquartered in Johnson City, Tennessee, specializing in innovative skin science solutions and advanced manufacturing services. The company operates across four distinct divisions including aesthetics, consumer skincare, prescription pharmaceuticals, and therapeutic products, distributing to over 60 countries worldwide. Crown Laboratories provides comprehensive contract development and manufacturing services with specialized capabilities in liquid, lotion, cream, gel, and ointment dosage forms through validated manufacturing processes and meticulous quality control standards. The Tennessee-based facility employs over 400 skilled professionals who deliver science-based pharmaceutical solutions across multiple therapeutic areas. Crown Laboratories maintains rigorous regulatory compliance and manufacturing excellence, supporting both proprietary brands like StriVectin, Blue Lizard, and PanOxyl, as well as custom development projects for pharmaceutical partners. The company leverages advanced formulation technologies and stability testing protocols to ensure product efficacy and safety throughout the development lifecycle. With over two decades of manufacturing expertise in Johnson City, Crown Laboratories has established itself as a trusted pharmaceutical partner, combining innovative research capabilities with scalable production infrastructure. The facility demonstrates commitment to quality through comprehensive regulatory oversight and continuous process improvement initiatives. Crown Laboratories continues expanding its manufacturing footprint while maintaining focus on delivering safe, effective pharmaceutical products that enhance patient outcomes and support global healthcare needs.

Currax Pharmaceuticals LLC is a Nashville-area pharmaceutical company headquartered in Brentwood, Tennessee, specializing in innovative medicines for patients with chronic and progressive diseases. The company operates as both a developer and distributor of branded and generic pharmaceutical products, maintaining a comprehensive portfolio that includes CONTRAVE, ONZETRA Xsail, SILENOR, and TREXIMET medications. As a vertically integrated pharmaceutical manufacturer, Currax Pharmaceuticals combines drug development capabilities with commercial distribution expertise to deliver life-changing treatments to patients worldwide. The company conducts clinical trials and provides independent research through educational grants, demonstrating commitment to advancing pharmaceutical science and patient care standards. Currax Pharmaceuticals has earned recognition as one of Nashville Business Journal Best Places to Work for three consecutive years, reflecting the company culture of challenging conventional pharmaceutical industry approaches while inspiring continuous innovation. Their manufacturing and development processes focus on chronic disease therapeutics, particularly in areas where patients face limited treatment options. The company strategic approach emphasizes enhancing medication access and improving patient outcomes through specialized pharmaceutical manufacturing and targeted drug development programs. Located in Tennessee thriving pharmaceutical corridor, Currax Pharmaceuticals leverages regional manufacturing advantages while maintaining global distribution capabilities for their branded product lines and generic pharmaceutical offerings.

Gregory Pharmaceutical Holdings, Inc. operates as a specialized pharmaceutical manufacturing company based in Memphis, Tennessee. The company focuses on developing, manufacturing, and distributing high-quality pharmaceutical products while maintaining strict adherence to FDA regulations and Good Manufacturing Practices (GMP). Their state-of-the-art facility in Memphis serves as a hub for pharmaceutical production, quality control, and distribution across the southeastern United States. The company provides comprehensive pharmaceutical manufacturing services including formulation development, analytical testing, packaging, and regulatory compliance support. Gregory Pharmaceutical Holdings specializes in both generic and proprietary drug manufacturing, utilizing advanced production technologies and automated systems to ensure consistent quality and efficiency. Their experienced team of pharmaceutical scientists, quality assurance professionals, and regulatory specialists work collaboratively to deliver products that meet the highest industry standards. With a commitment to innovation and patient safety, Gregory Pharmaceutical Holdings maintains rigorous quality management systems and invests in continuous process improvement. The company serves healthcare providers, distributors, and pharmaceutical partners throughout the region, offering flexible manufacturing solutions and reliable supply chain management. Their Memphis location provides strategic advantages for distribution and logistics, enabling efficient delivery of pharmaceutical products to markets across the United States while supporting local economic growth in the pharmaceutical sector.

GTx, Inc. operates as a specialized pharmaceutical manufacturing company based in Memphis, Tennessee, focusing on advancing healthcare through innovative drug development and manufacturing solutions. The company leverages its strategic location in the Mid-South region to serve pharmaceutical markets across North America while maintaining rigorous quality standards throughout its operations. As a dedicated pharmaceutical manufacturer, GTx, Inc. specializes in developing and producing high-quality pharmaceutical products through state-of-the-art manufacturing processes. The company maintains comprehensive quality control systems and adheres to strict FDA regulations and Good Manufacturing Practice guidelines to ensure product safety and efficacy. Their manufacturing capabilities encompass various pharmaceutical formulations and delivery systems designed to meet diverse therapeutic needs. GTx, Inc. distinguishes itself through its commitment to precision manufacturing and regulatory compliance. The Memphis facility features advanced production equipment and clean room environments that support sterile manufacturing operations. The company focuses on maintaining exceptional quality standards while providing cost-effective solutions for pharmaceutical development and production. The organization emphasizes continuous improvement in manufacturing processes and maintains strong partnerships with healthcare providers and pharmaceutical distributors. GTx, Inc. combines technical expertise with modern manufacturing infrastructure to deliver reliable pharmaceutical products that support improved patient outcomes and healthcare advancement throughout the region.

Hera Health Solutions represents a pioneering force in pharmaceutical manufacturing and drug delivery innovation based in Memphis, Tennessee. Founded in 2017, this specialized pharmaceutical device company focuses on the research, development, and commercialization of revolutionary long-acting treatments through proprietary bioerodible drug delivery implants. The company leverages advanced biomedical engineering expertise to manufacture innovative biodegradable implant systems that address critical healthcare challenges. Their patent-pending technology combines existing generic pharmaceuticals with FDA-approved structural materials to create next-generation drug delivery solutions. This breakthrough manufacturing approach completely eliminates the painful and costly implant removal procedures required by current market alternatives. Hera Health Solutions manufacturing capabilities center on precision-engineered bioerodible implants that provide sustained therapeutic release profiles. Their specialized production processes integrate materials science with pharmaceutical formulation expertise to deliver consistent, reliable dosage forms. The company maintains rigorous quality standards throughout their manufacturing operations, ensuring compliance with pharmaceutical industry regulations. Led by a team of biomedical engineers from Georgia Institute of Technology, the organization brings decades of experience in drug delivery system design, manufacturing optimization, and commercial scale-up. Their innovative manufacturing platform has earned recognition including victories at the Entrepreneurship World Cup 2023 and Arab Health Innov8 competition, demonstrating their commitment to advancing pharmaceutical manufacturing through cutting-edge implant technology solutions.

Medelis Inc is a specialized oncology Contract Research Organization based in Nashville, Tennessee, providing comprehensive drug development services for biotech and pharmaceutical sponsors. As a dedicated oncology CRO since 2008, Medelis focuses exclusively on phase I through phase III oncology trials, leveraging deep expertise in immuno-oncology and extensive investigator relationships across three continents. The company has successfully completed over 150 projects, demonstrating proven capabilities in pharmaceuticals, devices, and combination products. Medelis offers end-to-end services including study design, study launch, and study management, complemented by medical writing, drug development consulting, and study rescue capabilities. Their collaborative approach emphasizes relationships as their primary priority, delivering transparent pricing and cost certainty throughout project lifecycles. The organization maintains dedicated project managers and specialized oncology expertise at every trial stage, enabling rapid study start-up and flexible resourcing solutions. What distinguishes Medelis in the competitive pharmaceutical research landscape is their laser focus on oncology indications combined with rapid deployment capabilities and comprehensive regulatory compliance expertise. Their experienced team provides strategic guidance and operational excellence, helping sponsors navigate complex drug development pathways efficiently. By maintaining strong investigator networks and delivering consistent quality standards, Medelis has established itself as a trusted partner for organizations developing innovative cancer therapies and advancing oncology research.

Meridian Life Science, Inc. operates as a leading pharmaceutical manufacturing company based in Knoxville, Tennessee, specializing in molecular reagents and antibody production for the life sciences industry. The company delivers innovative solutions to pharmaceutical manufacturers, diagnostic laboratories, and research institutions worldwide through advanced biotechnology manufacturing capabilities. The company excels in developing precision molecular reagents and therapeutic antibodies that support drug discovery, diagnostic testing, and pharmaceutical research applications. Their state-of-the-art manufacturing facilities in Tennessee utilize cutting-edge biotechnology processes to produce high-quality reagents that meet stringent pharmaceutical industry standards and regulatory requirements. Meridian Life Science focuses on custom manufacturing services, providing contract production for pharmaceutical companies requiring specialized molecular components. Their technical expertise encompasses protein expression, purification technologies, and quality assurance systems designed to support critical pharmaceutical development programs. The company serves as a trusted manufacturing partner for organizations developing diagnostic assays, therapeutic compounds, and research tools. Their commitment to scientific innovation and manufacturing excellence has established them as a reliable supplier in the pharmaceutical supply chain. With comprehensive quality control systems and regulatory compliance protocols, Meridian Life Science ensures consistent product quality and reliable delivery schedules. The company continues expanding its manufacturing capabilities to meet growing demand for specialized pharmaceutical reagents and supports the advancement of medical research and drug development initiatives across multiple therapeutic areas.

Monarch Pharmaceuticals Inc stands as a distinguished pharmaceutical manufacturing company based in Bristol, Tennessee, with a rich heritage spanning over two decades in the industry. Originally established in 1994, the company has evolved into a trusted leader in branded prescription pharmaceutical development and manufacturing, serving both domestic and international markets. The Bristol facility operates as a comprehensive pharmaceutical production center, specializing in advanced drug development, formulation services, and commercial-scale manufacturing across multiple therapeutic categories. The company has built its reputation on rigorous quality standards and innovative manufacturing processes, maintaining state-of-the-art production capabilities that support both branded and generic pharmaceutical products. With a workforce of experienced pharmaceutical professionals, Monarch Pharmaceuticals delivers end-to-end solutions from initial compound development through final product commercialization. The Tennessee-based operation leverages cutting-edge technology and adheres to strict FDA compliance protocols, ensuring consistent product quality and regulatory adherence. Monarch Pharmaceuticals has established itself as a strategic partner for pharmaceutical companies seeking reliable contract manufacturing and development services. The company continues to expand its capabilities in specialized drug formulations, maintaining its position as a key player in the pharmaceutical manufacturing sector throughout the southeastern United States.

People's Custom Rx operates as a specialized compounding pharmacy serving Memphis, Tennessee and beyond since 1969. This pharmaceutical facility focuses on custom medication preparation, addressing unique patient needs through personalized therapeutic solutions. The company maintains state-of-the-art compounding laboratories utilizing pharmaceutical grade chemicals and advanced equipment to prepare specialized medications. Their comprehensive services include hormone therapy compounding, pain management formulations, sterile compounding procedures, and veterinary pharmaceutical preparations. People's Custom Rx excels in creating discontinued or unavailable commercial medications, particularly serving patients with autism, erectile dysfunction, and hormone replacement therapy needs. With 180 combined years of clinical experience among their specialized staff, the pharmacy demonstrates exceptional expertise in compounding techniques and therapeutic applications. The facility maintains memberships with the International Academy of Compounding Pharmacists and Pharmacy Compounding Accreditation Board, ensuring adherence to industry standards and best practices. Their operational efficiency includes 24-hour prescription preparation capabilities, online refill systems, and comprehensive delivery options including local service and nationwide shipping. The company leverages modern technology through mobile applications and drug interaction screening systems to enhance patient safety and convenience. People's Custom Rx commitment to quality compounding maximizes therapeutic outcomes for patients requiring specialized pharmaceutical solutions that traditional manufacturing cannot provide.

Plough Center for Sterile Drug Delivery Solutions, located in Memphis, Tennessee, serves as a specialized pharmaceutical manufacturing facility dedicated to advancing innovative medicines from discovery through clinical production. This FDA and State of Tennessee Health Department registered facility operates under cGMP compliance standards, providing comprehensive sterile formulation solutions for pharmaceutical companies and research institutions. The center operates a state-of-the-art 3,900 square foot cleanroom facility equipped with advanced barrier and isolator technology, staffed by PhD-level operators who ensure the highest quality manufacturing standards. Their extensive capabilities include aseptic fill and finish operations for vials, prefilled syringes, and cartridges, along with specialized lyophilization services in both organic and aqueous media. Plough Center excels in manufacturing complex pharmaceutical products including monoclonal antibodies, liposomes, lipid nanoparticles, and emulsions. The facility handles potent and cytotoxic compounds while offering particle reduction through homogenization and extrusion processes. Their novel formulation platforms specialize in nanoemulsions and nanosuspensions, positioning them at the forefront of drug delivery innovation. Additional services encompass sterile ophthalmic formulations, analytical method development and validation, and comprehensive stability studies. As an FDA registered 503B compounding facility with cGMP quality attributes, Plough Center bridges the critical gap between pharmaceutical research and commercial manufacturing, expediting life-saving medicines to market through their specialized sterile drug delivery expertise.